GlassScriptPhysician profile
Nicole Rahn
NPI 1497989610
$1,115.28
in general payments reported to CMS, 2019-2025
11 companies · $27.53 in 2025
The $27.53 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $155 · 2021: $158 · 2022: $73.21 · 2023: $59.04 · 2024: $459 · 2025: $27.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $604.11 | 2019-2024 | Citrefix, Easyfuse, Viaflow |
| Biotissue Holdings INC. | $139.69 | 2024 | |
| Abbott Laboratories | $136.60 | 2021 | |
| Reapplix INC. | $82.51 | 2024 | 3c Patch Kit - Box |
| Organogenesis INC. | $35.17 | 2020-2021 | |
| Nevro Corp. | $31.72 | 2023 | Senza |
| Smith+Nephew, INC. | $27.53 | 2025 | Grafix Pl |
| Abbvie INC. | $18.21 | 2024 | |
| Integra Lifesciences Corporation | $15.06 | 2019 | |
| Bioventus LLC | $12.63 | 2022 | |
| Paratek Pharmaceuticals, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Rahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.